NuVasive, Inc., a medical device company, focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery in the spine surgery market worldwide. The company’s product portfolio is focused on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. The company’s principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The MAS platform combines three categories of solutions that collectively minimize soft tissue disruption during spine fusion surgery, provide maximum visualization and are designed to enable safe and reproducible outcomes for the surgeon and the patient. The platform includes the company’s proprietary software-driven nerve detection and avoidance systems, NVM5, and Intraoperative Monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Many of the company’s products, including the individual components of its MAS platform could also be used in open or traditional spine surgery. The company’s spine surgery product line offerings, which include products for the thoracolumbar and the cervical spine, are primarily used to enable surgeon access to the spine to perform restorative and fusion procedures in a minimally-disruptive fashion. The company also launched Integrated Global Alignment (iGA) in which products and computer assisted technology under its MAS platform help achieve more precise spinal alignment. The company’s biologics products, which are used to aid in the spinal fusion process or bone healing process include allograft (donated human tissue) and synthetic offerings. In addition, following the company’s acquisition of Ellipse Technologies, Inc., which closed in February 2016, the company offers magnetically adjustable implant systems based on the MAGnetic External Control (MAGEC) technology platform. The company continues to focus research and development efforts to expand its MAS product platform and advance the applications of its technology into procedurally-integrated surgical solutions that improve clinical and economic outcomes. The company’s MAS platform enables a lateral procedure known as eXtreme Lateral Interbody Fusion (XLIF) in which surgeons access the spine for a fusion procedure from the side of the patient’s body, rather than from the front or back. Commercial Products The company’s MAS platform allows surgeons to perform a range of minimally-disruptive spine procedures in all regions of the spine and from various surgical approaches, while overcoming the shortcomings of traditional minimally invasive spine surgical techniques. The MAS platform is designed to treat a range of spinal pathologies while accommodating a surgeon’s preferred surgical technique. The company’s products facilitate minimally-disruptive applications of various spine surgery procedures, among others, such as lumbar and thoracic fusion procedures in which the surgeon approaches the spine through the patient’s back, side or abdomen; cervical fusion procedures for either the posterior occipito-cervico-thoracic region or the anterior cervical region; and decompression, which is removal of a portion of bone or disc from over or under the nerve root to relieve pinching of the nerve. The company’s MAS platform combines three product categories, its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves while directing customized access to the spine for implant delivery. Biologics are used to complement procedures by assisting in the bone healing process. MaXcess MaXcess retractors have a split-blade design consisting of three blades that could be positioned to customize the surgical exposure in the shape and size specific to the surgical requirements rather than the more traditional fixed tube or two-blade designs of traditional minimally invasive spine surgical systems. This split-blade design also provides customizable access
nuvasive inc (NK8:Frankfurt)
7475 Lusk Boulevard
San Diego, CA 92121
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for NK8.|
|View Industry Companies|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact NUVASIVE INC, please visit www.nuvasive.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.